Design Therapeutics (DSGN) Prepaid Assets (2020 - 2026)
Design Therapeutics' (DSGN) quarterly Prepaid Assets came in at $4.2 million in Q1 2026, up 6.45% year-on-year from $4.0 million in Q1 2025, and up 7.29% quarter-over-quarter from $3.9 million in Q4 2025.
Design Therapeutics (DSGN) Prepaid Assets (2020 - 2026) Analysis & Trends
Design Therapeutics has disclosed Prepaid Assets across 7 years of filings, most recently posting $4.2 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $4.2 million, up 6.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 million (up 6.45% YoY), and the FY2025 annual result was $3.9 million, up 203.0% from the prior year.
- Prepaid Assets came in at $4.2 million for Q1 2026 at Design Therapeutics, up from $3.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $4.2 million in Q1 2026 to a low of $1.3 million in Q4 2024.
- The 5-year median for Prepaid Assets is $3.1 million (2025), against an average of $2.9 million.
- Across the five-year window, Prepaid Assets surged 538.8% in 2022 and sank 62.57% in 2023, its largest moves.
- Design Therapeutics' Prepaid Assets stood at $3.6 million in 2022, then tumbled by 62.57% to $1.4 million in 2023, then retreated by 3.99% to $1.3 million in 2024, then soared by 203.0% to $3.9 million in 2025, then advanced by 7.29% to $4.2 million in 2026.
- The last three Prepaid Assets figures came in at $4.2 million (Q1 2026), $3.9 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Design Therapeutics | 641.99 Mn | 419.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.23 Mn |
| Dec 31, 2025 | 3.94 Mn |
| Sep 30, 2025 | 3.06 Mn |
| Jun 30, 2025 | 3.52 Mn |
| Mar 31, 2025 | 3.97 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 3.17 Mn |
| Jun 30, 2024 | 2.43 Mn |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 1.35 Mn |
| Sep 30, 2023 | 2.40 Mn |
| Jun 30, 2023 | 2.96 Mn |
| Mar 31, 2023 | 3.55 Mn |
| Dec 31, 2022 | 3.62 Mn |
| Sep 30, 2022 | 3.51 Mn |
| Jun 30, 2022 | 2.35 Mn |
| Mar 31, 2022 | 2.65 Mn |
| Dec 31, 2021 | 1.37 Mn |
| Sep 30, 2021 | 1.57 Mn |
| Jun 30, 2021 | 1.86 Mn |